A newly identified trigger of brain inflammation could offer a fresh target for slowing Alzheimer's progression.
The brain has its own built-in immune system that identifies threats and responds to them. In Alzheimer's disease, growing evidence shows that this system becomes persistently overactive. The result is chronic inflammation that damages the connections between brain cells.
In a preclinical study using human Alzheimer's brain cells, scientists at Scripps Research have identified a molecular trigger behind this process. The finding points to a potential drug target that could help control harmful inflammation.
A Molecular Switch Behind Inflammation
The study, published in Cell Chemical Biology, focuses on a protein called STING. Under normal conditions, STING acts as part of the immune system's early warning network. In Alzheimer's brains, however, researchers found that STING undergoes a chemical change called S-nitrosylation (or SNO, a reaction involving sulfur, oxygen and nitrogen). This modification drives the protein into an overactive state. When scientists blocked this change in a mouse model, brain inflammation was reduced.
"This is a new and important therapeutic target for Alzheimer's disease," says senior author Stuart Lipton, the Step Family Foundation Endowed Chair at Scripps Research and a clinical neurologist. "It's exciting to see that blocking this switch in mice reduces inflammation and protects the very brain cell connections that are lost in Alzheimer's, especially because we found the same pathway to be activated in human Alzheimer's brain samples and in human stem cell-derived models."
More than 30 years ago, Lipton, who also co-directs the Neurodegeneration New Medicines Center at Scripps Research, first described S-nitrosylation. In this process, a molecule related to nitric oxide (NO) attaches to a cysteine amino acid in proteins, forming "SNO" and altering how the protein behaves.
His lab later showed that SNO can be triggered by aging, inflammation, and environmental exposures such as air pollution and wildfire smoke. These changes can disrupt many proteins throughout the body. This widespread effect, referred to as a "SNO-STORM," has been linked to diseases including cancer, Parkinson's disease, and Alzheimer's.
Pinpointing STING's Weak Spot
In the new study, researchers took a closer look at STING, which had already been associated with Alzheimer's-related inflammation. Lipton's team, led by postdoctoral researcher Lauren Carnevale, worked with Professor John Yates III, a mass spectrometry expert at Scripps Research and holder of the John Lytton Young Endowed Chair.
They identified the exact location where S-nitrosylation occurs on STING, focusing on a single amino acid known as cysteine 148. When this site is modified, STING forms clusters and sets off inflammatory signaling.
Elevated levels of this altered form, called SNO-STING, were detected in postmortem brain tissue from Alzheimer's patients, in lab-grown human brain immune cells exposed to Alzheimer's proteins, and in mice with the disease.
Further experiments revealed that hallmark Alzheimer's protein clumps, including amyloid-beta and alpha-synuclein, can directly trigger S-nitrosylation of STING. This suggests a feedback loop. Protein buildup, along with aging and environmental stress, may spark inflammation that produces nitric oxide. That, in turn, modifies STING and amplifies inflammation even further.
Protecting Brain Connections
To test this mechanism, the team created a version of STING that lacks cysteine 148, preventing the S-nitrosylation step. When introduced into a mouse model of Alzheimer's, this modified protein significantly reduced inflammation in brain immune cells.
Importantly, it also preserved synapses, the connections between nerve cells that are essential for memory and thinking. Loss of synapses is closely linked to cognitive decline in dementia, so protecting them is a key goal in Alzheimer's research.
"What makes this target particularly promising is that we can quiet the pathological overactivation of STING without shutting down the normal immune response," says Lipton. "You still need STING to protect yourself from infections, and when we target cysteine 148, we're not blocking the entire molecule; we're just preventing STING from becoming overactivated."
Lipton's team is now developing small molecules designed to block cysteine 148, with plans to test them in future preclinical studies.
Reference: "Redox regulation of neuroinflammatory pathways contributes to damage in Alzheimer's disease brain" by Lauren N. Carnevale, Piu Banerjee, Xu Zhang, Jazmin Navarro, Charlene K Raspur, Parth Patel, Tomohiro Nakamura, Emily Schahrer, Henry Scott, Nhi Lang, Jolene K. Diedrich, Amanda J. Roberts, John R. Yates and Stuart A. Lipton, 23 April 2026, Cell Chemical Biology.
DOI: 10.1016/j.chembiol.2026.03.017
This work was supported in part by the National Institutes of Health (R35 AG071734, U01 AG088679, RF1 AG057409, R01 AG078756, R01 AG056259, R01 DA048882, DP1 DA041722 and R01 AG077046), and the U.S. Department of Defense/U.S. Department of the Army (AR230101).
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Your Voice May Reveal How Fast Your Brain Is Aging
Researchers have developed a machine-learning “speech clock” that estimates age from subtle patterns in how people speak and what they say. It is possible that people’s voices may contain certain signals of aging that [...]
Optogenetics Pioneers Win 2026 Nobel Prize in Physiology or Medicine
The 2026 Nobel Prize in Physiology or Medicine has been awarded to Peter Hegemann, Georg Nagel, and Karl Deisseroth for the development of optogenetics, a revolutionary technology that uses light to control individual neurons [...]
Molecular Manufacturing: The Future of Nanomedicine – From NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
What is ‘American Covid’ and how bad is it?
Cases of so-called ‘American Covid’ are on the rise in the UK. The strain is officially called XFG, or ‘Stratus’, and is the most common variant in North America, hence the name. It might soon [...]
Researcher at Russian plague laboratory dies of ‘unknown’ infection
Russian authorities have imposed "anti-epidemic measures" after a laboratory worker at an institute in Siberia dedicated to studying the plague and other infectious diseases died of a mysterious illness. The researcher, a 28-year-old female [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
A Surprising Brain Signal Could Explain Why Eating Less Protein Extends Lifespan
A new paper suggests that limiting protein intake triggers a coordinated response throughout the body that may help explain how protein restriction affects healthy aging. Animals respond to protein restriction, or reduced protein in [...]
Back and shoulder surgery is often worse than useless
Millions of operations should be scrapped SIX IN TEN Britons have surgery at some point. So do lots of Americans, at a cost of perhaps $500bn a year, a third of all spending on [...]
Cocaine plays with mind, hijacks brain circuit, drives increasingly rigid and repetitive behavior
Researchers have found that cocaine hijacks brain circuit, which to drive increasingly rigid and repetitive behavior. The brain circuit that normally participates in selecting natural mouth and face movements, but which becomes disproportionately engaged [...]
Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma
The brain cancer glioblastoma is one of the most aggressive and treatment-resistant cancers known to medicine, carrying a median survival of just 12-15 months, even with the best available care. Now, researchers at the [...]
New Treatment Cuts “Bad” Cholesterol in Half for a Full Year
A single infusion of an experimental CRISPR-Cas9 therapy was reported to safely lower LDL cholesterol by 52.5% and triglycerides by 47.8%, as measured 12 months after treatment. What if one infusion could keep cholesterol [...]
Too Much RNA Can Drain a Cell’s Energy, Scientists Discover
A virus may cripple a cell’s power supply simply by producing too much of a molecule the cell needs to survive. New research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences [...]
West African scientists warn of weakening health systems and urge stronger outbreak detection
LOME, Togo (AP) — West African laboratory scientists called on governments Friday to strengthen capacity to detect disease outbreaks to avoid another major outbreak, saying health systems across the region are becoming weaker. Participants [...]
A Little-Known Protein Could Point to a New Way To Treat Alzheimer’s
A study suggests that increasing SORLA protein levels could help treat Alzheimer’s disease and other disorders involving tau protein. Increasing SORLA, a protein with a protective role in the brain, helped mice withstand damage [...]
Cancer’s Hidden Antioxidant Shield Helps It Escape the Immune System
Blocking an antioxidant protein that tumors use to suppress immune attacks improved cancer immunotherapy responses in mice. Cancer cells can release antioxidants that interfere with the immune cells trying to kill them. Researchers have [...]
Scientists Find a Berry Compound That Helps Muscle Cells Burn Fat
Pterostilbene, a compound found naturally in some foods, affects how skeletal muscles process fats by stabilizing a protein called PPARδ and increasing its signaling activity. Pterostilbene, a natural compound found in blueberries, grapes, and [...]
